Tate & Lyle PLC
30 September 2008 - Tate & Lyle PLC
Director/PDMR Shareholding
Tate & Lyle PLC ('the Company') has been informed that the following persons
discharging managerial responsibility have acquired ordinary 25p shares
('Shares') in the capital of the Company:
-0-
*T
Name No of Shares Price per Date of Date Company
purchased Share transaction informed of
(pence) transaction
-------------------- ------------ ---------- -------------- --------------
Dr Robert Fisher* 800 386.284 26/09/08 29/09/08
-------------------- ------------ ---------- -------------- --------------
Karl Kramer 5,000 394.022 26/09/08 30/09/08
-------------------- ------------ ---------- -------------- --------------
*T
Mr Kramer's transaction was undertaken on the London Stock Exchange.
*Dr Fisher acquired 800 Shares by means of the purchase of 200 American
Depositary Receipts ('ADRs') (one ADR being equivalent to four Shares) on the
New York Stock Exchange at a price of 386.284 pence per share (being the
equivalent of 28.50 USD per ADR using an exchange rate of 1.8445).
This notification is made in accordance with DTR 3.1.4R(1)(a) of the FSA's
Disclosure and Transparency Rules.
-0-
*T
Lucie Gilbert
Deputy Company Secretary
*T
30 September 2008
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.